Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Novo Nordisk

Ozempic manufacturer Novo Nordisk spent $11 million last year 'wining and dining' doctors. Experts slam the move as a breach of doctor-patient trust

Do pharmaceutical companies have influence over your doctor's prescription pad? It's relatively easy to check—but you shouldn't have to, experts say.

Fortune

Ozempic under EU investigation over reports of suicidal thoughts

Three cases of suicidal and self-harm thoughts identified in Iceland, regulator says

The Independent UK

Ozempic shortages in the UK may last until 2024 – here’s why

A global shortage means some people with diabetes are struggling to access the drug semaglutide, which is sold under the brand name Ozempic.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Investigation into risk of suicidal and self-harm thoughts among users of Wegovy, Saxenda and other weight loss jabs

It will also look at one used to for type 2 diabetes

Wales Online

Drug regulator investigating suicidal thoughts among some weight-loss jab users

The European Medicines Agency is looking at Wegovy (semaglutide), Saxenda (liraglutide) and other similar drugs used to control appetite.

The Independent UK

Three cases of suicidal and self-harm thoughts identified in Iceland, regulator says

The Independent UK

Ozempic isn't alone. A whole class of 'revolutionary' weight-loss drugs is on the market—but only for the wealthy

“We're experiencing something here that is very, very different, very exciting from a healthcare perspective, and very expensive,” says Aon's Michael Manolakis.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Investors Seek Improved Weight-Loss Drugs With Focus On Nausea-Free Alternatives To Wegovy

Zenger

No more needles? A daily pill may work as well as Wegovy shots to treat obesity

Losing significant amounts of weight may soon be as easy as taking a daily pill

The Independent UK

Ozempic maker now wants to keep people from becoming obese in the first place

Novo Nordisk is investing in obesity prevention, the 'real big frontier' of weight loss.

Fortune

Diabetes Epidemic Makes this Stock a Strong Buy

Diabetes is a growing concern as more of the globe becomes modernized and with that is eating a diet that too often is a road to diabetes. Gladly there are drug companies at the forefront of this movement to stem the tide like Novo Nordisk (NVO) making it a very…

StockNews.com

Semaglutide: beware of buying the weight-loss drug online

A few years ago, celebrity weight-control practices were out of most people’s reach. Live-in chefs and personal trainers, not to mention elaborate surgical procedures like the Brazilian butt lift, were not real options for most. But with the advent of drugs such as semaglutide, it seems that anyone can go…

The Conversation

Wegovy is "not a magic bullet" - 3 doctors reveal what you need to know as the drug is set to be prescribed in the UK

As Wegovy is set to be available on prescription in the UK, we asked doctors what they think of the controversial weight loss injections

Woman & Home

Tilray Brands (TLRY) vs. Novo Nordisk (NVO): Which Pharma Stock Should You Buy?

The pharmaceutical sector performs relatively well during economic uncertainties due to inelastic demand for its products and services. While prominent players Tilray Brands (TLRY) and Novo Nordisk (NVO) should benefit, which stock is the better buy now? Read more to find out.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Marie Claire

As Serena Williams Opens Up About Her Ozempic Fat Loss Journey – We Spoke to Top Experts About the Repercussions

The tennis champion shared her decision to take this step was multi-faceted and motivated by a desire to "be at a healthy place."

Chronicle Live

How the new 'game-changing' weight loss drug works, who is eligible and when it will be available in UK

The National Institute for Health and Care Excellence gave approval for the use of appetite suppressant Wegovy (semaglutide) earlier this year - here are more details about it

The Independent UK

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood

Ministers have announced plans which could see tens of thousands given access to new weight-loss drug

Barchart

Why You Should Go Overweight On Novo Nordisk Stock

Novo Nordisk is already the global kingpin in diabetes treatments, with about 30% of the $50+ billion global diabetes market and around half of the $20 billion insulin therapy market. Now, it is becoming a powerhouse in weight-loss drugs, thanks to its Wegovy drug.

Get all your
news in one place.

100's of premium titles.
One news app.

LiveScience

Watch out for Ozempic copycats containing unauthorized active ingredients, FDA warns

Some compounding pharmacies are using unauthorized active ingredients to make copycat versions of Ozempic and Wegovy.

The Guardian - UK

Friday briefing: Are appetite-suppressing drugs really a fast track to weight loss?

In today’s newsletter: Semaglutide has won endorsements from celebrities and expert drugs advisers and has gone viral on TikTok. But don’t expect a quick fix

WEKU

Families scramble to find growth hormone drug as shortage drags on

Children who need growth hormone to achieve their full stature are having trouble getting the medicine. A shortage has stretched months longer than expected and could last the rest of the year.

The Independent UK

WHO issues warning on weight loss drugs

Balanced diet and exercise remain key to losing weight, health body says

Reuters

Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review

New highly-effective weight loss drugs such as Novo Nordisk's Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years.

The Independent UK

What's behind shortages of Adderall, Ozempic and other meds?

Drug shortages are growing in the United States, and experts see no clear path to resolving them

The Guardian - UK

Can drugs fix the UK’s adolescent obesity crisis?

A powerful new weight-loss medication may be approved for those aged 12 to 17. But healthcare professionals fear it ignores the underlying socioeconomic causes

1 … 23 24 25 26

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.